Literature DB >> 24855203

The autonomic nervous system and hypertension.

Giuseppe Mancia1, Guido Grassi2.   

Abstract

Physiological studies have long documented the key role played by the autonomic nervous system in modulating cardiovascular functions and in controlling blood pressure values, both at rest and in response to environmental stimuli. Experimental and clinical investigations have tested the hypothesis that the origin, progression, and outcome of human hypertension are related to dysfunctional autonomic cardiovascular control and especially to abnormal activation of the sympathetic division. Here, we review the recent literature on the adrenergic and vagal abnormalities that have been reported in essential hypertension, with emphasis on their role as promoters and as amplifiers of the high blood pressure state. We also discuss the possible mechanisms underlying these abnormalities and their importance in the development and progression of the structural and functional cardiovascular damage that characterizes hypertension. Finally, we examine the modifications of sympathetic and vagal cardiovascular influences induced by current nonpharmacological and pharmacological interventions aimed at correcting elevations in blood pressure and restoring the normotensive state.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  hypertension; parasympathetic nervous system; sympathetic nervous system

Mesh:

Year:  2014        PMID: 24855203     DOI: 10.1161/CIRCRESAHA.114.302524

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  164 in total

1.  Metaboreflex activation delays heart rate recovery after aerobic exercise in never-treated hypertensive men.

Authors:  Tiago Peçanha; Leandro Campos de Brito; Rafael Yokoyama Fecchio; Patricia Nascimento de Sousa; Natan Daniel da Silva Junior; Andrea Pio de Abreu; Giovanio Vieira da Silva; Décio Mion-Junior; Cláudia Lúcia de Moraes Forjaz
Journal:  J Physiol       Date:  2016-09-21       Impact factor: 5.182

Review 2.  Device-Guided Breathing for Hypertension: a Summary Evidence Review.

Authors:  Kamal R Mahtani; Tumas Beinortas; Karolis Bauza; David Nunan
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

3.  "Broken" autonomic cardiac circadian clock in obese adolescents: evidence and implications.

Authors:  Guido Grassi
Journal:  Clin Auton Res       Date:  2014-11-01       Impact factor: 4.435

4.  Sympathetic reactivity in young women with a family history of hypertension.

Authors:  Jody L Greaney; Evan L Matthews; Megan M Wenner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

Review 5.  Carotid baroreflex activation therapy for resistant hypertension.

Authors:  Ronald G Victor
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

Review 6.  The baroreflex as a long-term controller of arterial pressure.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Physiology (Bethesda)       Date:  2015-03

Review 7.  Sleep Duration and Blood Pressure: Recent Advances and Future Directions.

Authors:  Nour Makarem; Ari Shechter; Mercedes R Carnethon; Janet M Mullington; Martica H Hall; Marwah Abdalla
Journal:  Curr Hypertens Rep       Date:  2019-04-05       Impact factor: 5.369

8.  Not all posttraumatic stress disorder symptoms are equal: fear, dysphoria, and risk of developing hypertension in trauma-exposed women.

Authors:  Jennifer A Sumner; Laura D Kubzansky; Andrea L Roberts; Qixuan Chen; Eric B Rimm; Karestan C Koenen
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

Review 9.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

10.  Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats.

Authors:  Anne M Fink; Caron Dean
Journal:  J Vis Exp       Date:  2018-09-11       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.